Comparison between the two drug regimens for the treatment of H.pylory infectio

Phase 4

Recruiting

• Conditions: Helicobacter pylori [H. pylori].; Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere; B96.81

• Registration Number: IRCT20230902059322N1
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 86

Inclusion Criteria

Proof of H. pylori infection by rapid urease test or histological evaluation of gastric antrum and corpus callosum samples by Giemsa staining
Informed consent of the patient

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Eradication of H. pylori, evaluated by urine stool antigen test. Timepoint: 8 weeks after the end of treatment. Method of measurement: urine stool antigen test.